Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-05-03
2010-02-02
Kolker, Daniel E. (Department: 1649)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C424S139100, C424S158100
Reexamination Certificate
active
07655760
ABSTRACT:
The present invention relates to a novel human protein called phosphatonin, and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to this novel human protein.
REFERENCES:
patent: 5340934 (1994-08-01), Termine et al.
Denhardt et al. Osteopontin: a protein with diverse functions. FASEB J. Dec. 1999;7(15):1475-82.
Aschinberg,J. Pediatr., 91 (1977) 55-60.
Carpenter,Pediatric Clinics of North America, 44 (1997) 443-466.
Drenzer,Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism(ed. Favus, M.J.) 184-188 (Am. Soc. Bone and Min. Res., Kelseyville, CA 1990).
Escarot,J. Bone Miner. Res., 7 (1992) 215-220.
Escarot,J. Bone Miner. Res., 10 (1995) 424-431.
Econs,Am. J. Physiol., 273 (1997) F489-F498.
Francis,Nat. Genet., 11 (1995), 130-136.
Francis,Baillieres Clinical Endrocrinology and Metabolism, 11 (1997) 145-163.
Glorieux,Arch. Pediat., 4 (1997) 102s-105s.
Grieff,Current Opinion in Nephrology&Hypertension, 6 (1997) 15-19.
Hanna,Current Therapy in Endocrinology&Metabolism, 6 (1997) 533-540.
Henderson, J. and Wang, D.Curr. Opin. Orthopaedics, 10 (1999) 3444-353.
Hilfiker,PNAS, 95(24) (1998) 14564-14569.
Ioakimidis,The J. Rheumatology, 21(6) (1994) 1162-1164.
Kumar,Nephrol. Dial. Transplant, 12 (1997) 11-13.
Lajeunesse ,Kidney Int., 50 (1996) 1531-1538.
Lyles,Ann Intern. Med., 93 (1980) 275-278.
Meyer,J. Bone Miner. Res., 4 (1989) 493-500.
Meyer,J. Bone Miner. Res., 4(4) 1989) 523-532.
Miyauchi,J. Clin. Endocrinol Metab., 67 (1988) 46-53.
Morgan,Arch. Intern, Med., 134 (1974) 549-552.
Nesbitt,J. Clin, Invest., 89 (1992) 1453-1459.
Nesbitt,J. Bone Miner. Res., 10 (1995) 1327-1333.
Nesbitt,Endocrinology, 137 (1996) 943-948.
Popovtzer,Clin. Res. 29 (1981), 418A (Abstract).
Qui,GEnet. Res. Camb., 62 (1993) 39-43.
Rowe,Hum. Genet., 94 (1994) 457-467.
Rowe,Bone, 18 (1996) 159-169.
Rowe,Hum. Genet., 97 (1996) 345-352.
Rowe,Hum. Mol. Genet., 6 (1997) 539-549.
Rowe,Exp. Nephrol., 5 (1997) 355-363.
Rowe,Current Opinion in Nephrology&Hypertension, 7(4) (1977) 367-376.
Shane,Journal of Bone and Mineral Research, 12 (1997) 1502-1511.
Weidner,Cancer, 59 (1987) 1442-1454.
Slatopolsky et al., J. Amer. Soc. Nephrol. 2003, vol. 14, suppl., s297-s299.
Bozicevic Karl
Bozicevic Field & Francis LLP
Emch Gregory S
Kolker Daniel E.
The University College London
LandOfFree
Antibodies to the polypeptide hormone phosphatonin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to the polypeptide hormone phosphatonin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to the polypeptide hormone phosphatonin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4235383